Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. Reports 2nd Quarter 2001 Results
DaVita Inc. , today announced results for the period ended June 30, 2001. Net earnings for the second quarter and six months ended June 30, 2001 were $23.2 million or $0.26 per share and $44.6…
-
DaVita Inc. Extends Exchange Offer Expiration Date
DaVita Inc. announced today that it has extended the expiration date of its offer to exchange its 9 3% Series B Senior Subordinated Notes due 2011, registered under the Securities Act, for its…
-
DaVita Inc. Announces Exchange Offer for its 9 1/4% Senior Subordinated Notes Due 2011
DaVita Inc. announced today its offer to exchange $225 million of its 9 1/4% Senior Subordinated Notes due 2011, which have been registered under the Securities Act of 1933, for its outstanding 9…
-
Davita Announces Second Quarter Earnings Release
We are planning to release our second quarter financial results on Thursday, August 2, 2001. A conference call to discuss the Q2 operating results is scheduled for 10:30 a.m. Pacific Time on…
-
Nancy-Ann DeParle and William L. Roper Join DaVita Board of Directors
DaVita Inc. announced today that Nancy-Ann DeParle and William L. Roper have joined its Board of Directors. As expected, Thomas A. Scully has resigned his position on the DaVita Board of Directors…
